Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.786
Peer-review started: March 3, 2022
First decision: April 17, 2022
Revised: May 4, 2022
Accepted: August 5, 2022
Article in press: August 5, 2022
Published online: September 15, 2022
Processing time: 189 Days and 22.8 Hours
Insulin resistance is a condition in which muscle cells take up and store glucose and triglycerides, resulting in elevated amounts of glucose and triglycerides circulating in the bloodstream.
Several bibliometric studies have been carried out on the subject of diabetic investigation. However, no bibliometric study has been done on research into insulin resistance.
This bibliometric study aimed to identify and assess the current state and trends in insulin resistance research production worldwide and visually analyze research hotspots on this subject.
The Scopus database and Reference Citation Analysis were used to compile the literature on insulin resistance. In addition, VOSviewer software was used to visually assess data collected from relevant publications.
This is the first bibliometric analysis of trends in insulin resistance. The number of publications on insulin resistance has increased in the last decade. Our results indicated that the “inflammatory mechanisms in the regulation of insulin resistance” and “mechanisms linking obesity to insulin resistance” will remain research hotspots in the future.
Our findings indicate that interest in insulin resistance has gradually increased among researchers, as shown by the increasing number of citations and annual publications. Moreover, publications in this field have increased significantly in the last decade, while low-income countries with higher burdens continue to produce fewer publications.
This paper contributes essential information by providing references and suggestions for future research on pathophysiology and clinical uses of insulin resistance. This approach may aid researchers in identifying new topics of inquiry and identifying research hotspots and frontiers. Perhaps in the future, high-quality clinical evidence will be collected.